Kitazato Corporation
Research Kitazato Corporation (368A.T) on Bullrun: market cap JPY 57.12B, P/E 13.7, dividend yield 2.9%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker368A.T
- ExchangeTSE
- CountryJapan
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyJPY
- Market capJPY 57.12B
- P/E13.7
- Dividend yield2.9%
- Financial periodFY2026
- RevenueJPY 10.95B
- Revenue growth6.3%
- Net incomeJPY 3.90B
- Free cash flowJPY 3.63B
- Gross margin65.9%
Valuation Snapshot
latest market cap is JPY 57.12B; P/E is 13.7; dividend yield is 2.9%.
Peer valuation comparison
Latest P/E is 13.74x versus a Healthcare sector median of 21.69x (36.7% below).
Latest dividend yield is 2.91% versus a Healthcare sector median of 2.41% (20.7% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | JPY 10.95B | JPY 3.90B | JPY 3.63B | 65.9% | 97.38 | JPY 13.41B | n/a | JPY 20.50B |
| FY2025 | JPY 10.30B | JPY 3.79B | JPY 2.62B | 67.7% | 94.72 | JPY 11.46B | n/a | JPY 18.25B |
| FY2024 | JPY 10.08B | JPY 3.97B | JPY 4.42B | 69.8% | 99.32 | JPY 10.50B | n/a | JPY 16.06B |
| FY2023 | JPY 9.35B | JPY 3.37B | JPY 2.05B | 71.6% | 84.25 | JPY 8.10B | n/a | JPY 14.09B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | JPY 57.12B | 13.7 | 2.9% | 41 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 41 JPY, yield 2.9%.
| Year | Dividends/share |
|---|---|
| FY2026 | 41 JPY |
About Kitazato Corporation
Kitazato Corporation researches, develops, manufactures, and markets medical devices, reagents, and related products for fertility treatment. It offers needles, catheters and cannulas, vitrification media and equipment, sperm processing medium/tools, IVF medium products, micro tools, and labware products. The company was formerly known as Kitazato Biopharma Co., Ltd. The company was founded in 1998 and is based in Shizuoka, Japan. Kitazato Corporation is a subsidiary of Kitasato Shoji Co., Ltd.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Kitazato Corporation's market cap?
Kitazato Corporation's market capitalization is JPY 57.12B.
What is Kitazato Corporation's P/E ratio?
Kitazato Corporation's price-to-earnings (P/E) ratio is 13.7.
Does Kitazato Corporation pay a dividend?
Kitazato Corporation has a dividend yield of 2.9%.
What does Kitazato Corporation do?
Kitazato Corporation researches, develops, manufactures, and markets medical devices, reagents, and related products for fertility treatment. It offers needles, catheters and cannulas, vitrification media and equipment, sperm processing medium/tools, IVF medium products, micro tools, and labware products. The company was formerly known as Kitazato Biopharma Co., Ltd. The company was founded in 1998 and is based in Shizuoka, Japan. Kitazato Corporation is a subsidiary of Kitasato Shoji Co., Ltd.